For­mer House Ma­jor­i­ty Leader Er­ic Can­tor has been cho­sen as PhRMA’s next pres­i­dent and CEO, the group said Tues­day. The an­nounce­ment came short­ly af­ter End­points...

Beam Ther­a­peu­tics, a Cam­bridge, MA, com­pa­ny de­vel­op­ing CRISPR base edit­ing ther­a­pies, has sued two Chi­nese sci­en­tists and two biotech com­pa­nies where they work for al­leged­ly...

Af­ter months of hunt­ing for po­ten­tial buy­ers of mul­ti­ple man­u­fac­tur­ing sites in Ger­many, BioN­Tech said it will close these fa­cil­i­ties af­ter be­ing un­able to lock...

UniQure's shares QURE were rocked Tues­day morn­ing af­ter the com­pa­ny re­vealed its ex­per­i­men­tal Hunt­ing­ton’s dis­ease gene ther­a­py may have less ben­e­fit than orig­i­nal­ly thought.

In...

Fre­se­nius Kabi will sell biosim­i­lars di­rect­ly to em­ploy­ers.

To ac­com­plish that, the drug­mak­er is work­ing with Ever­sana-owned Waltz Health, which runs a mar­ket­placethat helps...

SK pharmte­co plans to spend at least $200 mil­lion on build­ing out its de­vel­op­ment and man­u­fac­tur­ing in­fra­struc­ture over the next five years, which is ex­pect­ed...